Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
HELMY Eltoukhy's company is on a roll. The startup is a leading contender in the crowded field of firms working on "liquid biopsy" tests that aim to be able to tell in a single blood draw whether a person has cancer.
Venture investors are backing Guardant Health to